FDA Approvals in Oncology: April-June 2026
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
The June edition of Editors’ Picks from the AACR journals included studies on targeting neural cross-talk to stop glioblastoma...
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
For September 2025, the editors of AACR's journals highlighted studies on cervical cancer screening, supercharging immunotherapy, and more.
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and...
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...